Literature DB >> 11405651

Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific Therapy against Pseudomonas aeruginosa.

C Hennard1, Q C Truong, J F Desnottes, J M Paris, N J Moreau, M A Abdallah.   

Abstract

Pseudomonas aeruginosa is particularly resistant to most all the antibiotics presently available, essentially because of the very low permeability of its outer membrane. To overcome this, we synthesized four siderophore-based antibiotics formed by two quinolones - norfloxacin and benzonaphthyridone - bound to the pyoverdin of P. aeruginosa ATCC 15692 via two types of spacer arms: one stable and the other readily hydrolyzable. From the comparison of their antibacterial properties with those of the two unbound quinolones, we reached the following conclusions: (a) The adducts inhibit Escherichia coli's gyrase showing that the dissociation of the compounds is not necessary for their activity. However, the presence of the pyoverdin moiety on the molecule decreases the inhibition activity compared to the antibiotic alone. (b) They facilitate the uptake of (55)Fe using the specific pyoverdin-mediated iron-transport system of the bacterium. No uptake was observed either with P. aeruginosa ATCC 27853, which produces a structurally different pyoverdin, or with P. aeruginosa K690, which is a mutant of P. aeruginosa ATCC 15692 lacking FpvA, the outer-membrane pyoverdin receptor. (c) MIC determinations have shown that only strains P. aeruginosa ATCC 15692 and the derived outer-membrane receptor-producing but pyoverdin-deficient P. aeruginosa IA1 mutant present higher susceptibility to the pyoverdin-quinolone adducts, whereas P. aeruginosa ATCC 27853 and K690 are much more resistant. (d) Growth inhibition by these adducts confirmed these results and showed that the adducts with the hydrolyzable spacer arm have better activity than those with the stable one and that the labile spacer arm adducts present much higher activity than the quinolones alone. These results show clearly that the penetration of the antibiotic into the cells is favored when this latter is coupled with pyoverdin: Only the strains possessing the appropriate outer-membrane receptor present higher susceptibility to the adduct. In this case the antibiotic uses the pyoverdin-mediated iron-transport system. Furthermore, better efficiency is obtained when the spacer arm is labile and favors the antibiotic release inside the cell, allowing better inhibition of gyrase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405651     DOI: 10.1021/jm990508g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Siderophore-fluoroquinolone conjugates containing potential reduction-triggered linkers for drug release: synthesis and antibacterial activity.

Authors:  Cheng Ji; Marvin J Miller
Journal:  Biometals       Date:  2015-02-08       Impact factor: 2.949

2.  Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin-Ciprofloxacin Conjugate and Confers Targeted Antibacterial Activity.

Authors:  Wilma Neumann; Martina Sassone-Corsi; Manuela Raffatellu; Elizabeth M Nolan
Journal:  J Am Chem Soc       Date:  2018-04-10       Impact factor: 15.419

Review 3.  Exploiting bacterial iron acquisition: siderophore conjugates.

Authors:  Cheng Ji; Raúl E Juárez-Hernández; Marvin J Miller
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

4.  Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers.

Authors:  Cheng Ji; Marvin J Miller
Journal:  Bioorg Med Chem       Date:  2012-05-02       Impact factor: 3.641

5.  Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug.

Authors:  Benjamin D Reeves; Mark Young; Paul A Grieco; Peter Suci
Journal:  Biofouling       Date:  2013-08-19       Impact factor: 3.209

6.  Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii.

Authors:  Timothy A Wencewicz; Marvin J Miller
Journal:  J Med Chem       Date:  2013-05-08       Impact factor: 7.446

7.  FvtA is the receptor for the siderophore vanchrobactin in Vibrio anguillarum: utility as a route of entry for vanchrobactin analogues.

Authors:  Miguel Balado; Carlos R Osorio; Manuel L Lemos
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

8.  Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.

Authors:  Timothy A Wencewicz; Timothy E Long; Ute Möllmann; Marvin J Miller
Journal:  Bioconjug Chem       Date:  2013-02-14       Impact factor: 4.774

Review 9.  Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates.

Authors:  Timothy A Wencewicz; Ute Möllmann; Timothy E Long; Marvin J Miller
Journal:  Biometals       Date:  2009-02-17       Impact factor: 2.949

10.  Pseudomonas aeruginosa-plant root interactions. Pathogenicity, biofilm formation, and root exudation.

Authors:  Travis S Walker; Harsh Pal Bais; Eric Déziel; Herbert P Schweizer; Laurence G Rahme; Ray Fall; Jorge M Vivanco
Journal:  Plant Physiol       Date:  2003-12-30       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.